Literature DB >> 17921480

Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.

Ravet Stéphanie1, Soraya Labied, Silvia Blacher, Francis Frankenne, Carine Munaut, Viviana Fridman, Aude Beliard, Jean-Michel Foidart, Michelle Nisolle.   

Abstract

BACKGROUND: Levonorgestrel-releasing intrauterine system (LNG-IUS), although inserted to reduce heavy menstruation, causes irregular early transient bleeding. The objective of the study was to document quantitative changes in endometrial vessels of short- (< or =3 months) and long-term (> or =12 months) LNG users. The area, density and maturation of endometrial vessels were quantified in 19 endometrial biopsies of women with LNG-IUS and in 10 normally ovulating patients during mid-luteal phase.
METHODS: Vessel maturation was evaluated by double immunostaining using anti-von Willebrand factor (endothelial cell marker) and anti-alpha Smooth Muscle Actin (vascular smooth muscle cells) antibodies. Vessel area, number and density were quantified with a novel computer-assisted image analysis system.
RESULTS: Endometrium exposed to LNG-IUS for 1-3 months displayed a 11.5-fold increase in small naked vessel number. The partially mature vessel (alphaSMA partially positive) number increased six times. After long-term LNG-IUS treatment, the immature and partially mature vessel number remained four times higher than in the control group. Vessel area and density also increased dramatically in a time-dependent pattern with LNG-IUS use.
CONCLUSIONS: Levonorgestrel affects blood vessel number, area, density and maturation in a time-dependent pattern that may explain the early transient increase in breakthrough bleeding with the LNG-IUS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17921480     DOI: 10.1093/humrep/dem238

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  5 in total

Review 1.  Mechanisms of normal and abnormal endometrial bleeding.

Authors:  Charles J Lockwood
Journal:  Menopause       Date:  2011-04       Impact factor: 2.953

2.  Dilated thin-walled blood and lymphatic vessels in human endometrium: a potential role for VEGF-D in progestin-induced break-through bleeding.

Authors:  Jacqueline F Donoghue; C Jay McGavigan; Fiona L Lederman; Leonie M Cann; Lulu Fu; Eva Dimitriadis; Jane E Girling; Peter A W Rogers
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

3.  Levonorgestrel-IUS system and endometrial manipulation.

Authors:  Sonia Malik
Journal:  J Midlife Health       Date:  2013-01

4.  Development of an animal experimental model to study the effects of levonorgestrel on the human endometrium.

Authors:  M-L Alvarez Gonzalez; C Galant; F Frankenne; M Nisolle; S Labied; J-M Foidart; E Marbaix; A Béliard
Journal:  Hum Reprod       Date:  2008-12-17       Impact factor: 6.918

5.  Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one-year randomised controlled trial.

Authors:  Marie Mawet; Fabrice Nollevaux; Dominique Nizet; Fabienne Wijzen; Valérie Gordenne; Niso Tasev; Dimitrije Segedi; Bogdan Marinescu; Andreea Enache; Vadim Parhomenko; Francis Frankenne; Jean-Michel Foidart
Journal:  Eur J Contracept Reprod Health Care       Date:  2014-03-26       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.